Our team are experts in managing and evaluating images, especially with ocular diseases affecting the retina. As a trusted partner to sponsors and CROs, we provide domain expertise, innovative imaging tools, and scalable solutions.
A successful multi-center trial requires intrinsic understanding of various imaging techniques, developing meaningful outcome correlations, and formulating computational methodologies. Our insightful experts (several are board-certified ophthalmologists) help guide your selection of the right biomarkers that accurately reflect the characteristics of disease progression and treatment effects.
With MERIT, your ophthalmology study data and images can easily be shared between clinical sites, reading centers, CROs, and sponsors for maximum transparency. This makes managing global ophthalmic trials involving multiple reading centers and analysis of multiple modalities not only feasible, but practical.
MERIT provides consistent, high-quality independent reading center services.
Benefits:
AI: High-quality retinal images were key to this pilot study’s success and formed the basis for testing an AI algorithm....
Gene Therapy: MERIT’s imaging expertise and proprietary software played a vital role in gene therapy clinical trials....
Wet AMD: Our imaging expertise and proprietary software performed a crucial role in this global phase III wet AMD Study....
MERIT provides ECC analysis for the following ocular clinical trials:
